Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polymyxin B PK/PD study in refractory multidrug-resistant lung infection
ChiCTR2100042817Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Jan 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polymyxin B in pulmonary infection and bacterial pneumonia, sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Blood concentration of polymyxin B. Started Jan 2020; status: recruiting.
02
Drugs
polymyxin B
03
Conditions
pulmonary infectionbacterial pneumonia
Beyond the preview
Go deeper on ChiCTR2100042817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042817.